Consumer Defensive Earnings Report — 2026-07-16 to 2026-08-30

25 most recent Consumer Defensive earnings

1. Aug 27, 2026, 4:06 PM ET·LFVN·Consumer Defensive

   LifeVantage — Fourth Quarter and Full Fiscal Year 2026 Earnings Summary

   LIFEVANTAGE CORP

   Full Year 2026 revenue declined 20.1% to $182.6 million (vs. $228.5 million in 2025), while net income fell 48.0% to $5.1 million ($0.40/share) from $9.8 million ($0.75/share); Q4 2026 revenue dropped 23.1% to $42.4 million with net income of $1.3 million ($0.10/share). Active accounts contracted 21.2% to 104,000 and active customers fell 24.7% to 61,000 by June 30, 2026, driven by macroeconomic headwinds, lower order sizes, and reduced sales of the MindBody GLP-1 System. Gross margins compressed to 77.6% for the full year from 80.4% in 2025 due to product mix shifts, increased shipping costs, and a $2.5 million inventory obsolescence allowance for the MindBody GLP-1 System. Management is not issuing formal guidance for fiscal 2027 following a recent CEO transition; however, the company remains debt-free with $14.9 million in cash and has $58.5 million remaining under its $60 million share repurchase program.

2. Aug 27, 2026, 6:57 AM ET·DG·Consumer Defensive

   Dollar General Corporation — Second Quarter 2026 Earnings Summary

   DOLLAR GENERAL CORP

   Net sales rose 5.2% year-over-year to $11.3 billion, while diluted EPS increased 33.3% to $2.48, driven by a 127 basis point expansion in gross margin and a $0.25 per share benefit from tariff refunds. The company raised its full-year 2026 guidance, now anticipating net sales growth of 4.0% to 4.3%, same-store sales growth of 2.5% to 2.9%, and diluted EPS of $7.80 to $8.00. Capital allocation includes a quarterly dividend of $0.59 per share and a full-year share repurchase guidance of up to $700 million, supported by $1.5 billion in year-to-date operating cash flow. Strategic execution continues with 126 new stores opened in the quarter and 4,730 real estate projects planned for fiscal 2026, alongside $1.4 billion in expected capital expenditures.

3. Aug 27, 2026, 6:31 AM ET·DLTR·Consumer Defensive

   Dollar Tree, Inc. — Second Quarter Fiscal 2026 Earnings Summary

   DOLLAR TREE INC

   Net sales rose 7.0% year-over-year to $4.9 billion in Q2, while diluted EPS surged 260.0% to $2.70, a result significantly boosted by $1.31 in tariff refunds. The company raised its full-year fiscal 2026 adjusted diluted EPS guidance to $7.70–$8.05 (including ~$0.60 tariff benefit) and net sales guidance to $20.5–$20.7 billion, driven by 3–4% comparable store sales growth. Fiscal 2026 store activity is projected to include approximately 400 new openings and 75 closings, with Q3 net sales guidance set at $5.0–$5.1 billion and adjusted EPS at $0.80–$0.95. Capital allocation included $605 million in share repurchases during the quarter, leaving $2.5 billion remaining under the authorization, while the company maintains a debt-free position on its revolving credit facility.

4. Aug 26, 2026, 5:42 PM ET·HRL·Consumer Defensive

   Hormel Foods — Third Quarter Fiscal 2026 Earnings Summary

   HORMEL FOODS CORP

   Net sales declined 2.4% year-over-year to $2.96 billion, while adjusted diluted EPS rose to $0.37 from $0.35; GAAP diluted EPS fell to $0.11 from $0.33 due to significant discrete charges including a $56 million Brazil divestiture loss, a $48 million Indonesia impairment, and a $38 million litigation settlement. Fiscal 2026 guidance was updated to reflect a raised adjusted operating income range of $1.08 billion to $1.12 billion and adjusted diluted EPS of $1.45 to $1.51, both representing 6% to 10% growth, while GAAP operating income guidance was lowered to $0.83 billion to $0.87 billion to include the aforementioned discrete items. The Foodservice segment achieved its 12th consecutive quarter of organic net sales growth driven by premium proteins, whereas the Retail segment saw a 9% volume decline and the International segment reported a 254% drop in segment profit due to a non-cash impairment charge. The company completed the sale of its Brazil operations, which will be excluded from future organic comparisons, and returned $161 million to stockholders via dividends while maintaining $840 million in cash on hand.

5. Aug 26, 2026, 8:15 AM ET·BRLS·Consumer Defensive

   Borealis Foods — Six Months Ended June 30, 2026 Earnings Summary

   BOREALIS FOODS INC

   Preliminary revenue from the U.S. K–12 foodservice channel increased 110% year-over-year for the six months ended June 30, 2026, though specific total revenue, net earnings, and margin figures were not disclosed. The company expanded its U.S. K–12 footprint to over 20,000 schools across 2,500 districts, with products shipped via 106 distributors in 40 states over the past 12 months. Management expressed confidence in the channel's ability to support increased production volume and manufacturing utilization, citing strong feedback from school nutrition professionals at the 2026 Annual National Conference. The press release highlights risks regarding liquidity, financing requirements, and the ability to maintain compliance with Nasdaq continued listing requirements.

6. Aug 26, 2026, 7:02 AM ET·SJM·Consumer Defensive

   The J.M. Smucker Co. — Fiscal Year 2027 First Quarter Earnings Summary

   J M SMUCKER CO

   Net sales rose 5% year-over-year to $2.2 billion, while adjusted EPS surged 71% to $3.24, driven by a $0.84 benefit from tariff refunds and a shift from a prior-year loss of $0.41 per share. Full-year fiscal 2027 guidance was upgraded: adjusted EPS range increased to $10.50–$11.00 (previously $9.75–$10.25) and free cash flow to ~$1.1 billion (previously $1.0 billion), though net sales guidance was lowered to a 1.0%–2.0% decline (previously 3.0%–4.0% decline). Segment performance was mixed, with U.S. Retail Coffee sales up 13% and profit up 124%, while Sweet Baked Snacks sales fell 7% and profit dropped 13%; overall adjusted gross profit increased 28% to $950.2 million. Capital return initiatives included a quarterly dividend increase to $1.12 per share and $5.7 million in treasury share purchases, alongside $230.8 million in net cash outflows related to debt reduction.

7. Aug 25, 2026, 7:38 AM ET·MZTI·Consumer Defensive

   The Marzetti Company — Fiscal Year 2026 Earnings Summary

   MARZETTI CO

   Fiscal 2026 consolidated net sales rose 1.1% to $1.93 billion, while Q4 sales declined 2.2% to $465.0 million (adjusted up 0.4% excluding non-core TSA sales); full-year net income increased 14.5% to $191.6 million ($6.98 per share) and Q4 net income grew 48.5% to $48.3 million ($1.76 per share), driven by record gross profit and a $18.5 million gain on the Milpitas property sale. Gross margin improved 220 basis points to 24.5% in Q4 and 100 basis points to 25.0% for the full year, though Q4 SG&A expenses rose 19.9% to $74.3 million due to $10.5 million in acquisition-related costs and $1.6 million in amortization for the Bachan's intangible assets. The company returned $145.1 million to shareholders via $108.8 million in cash dividends and $36.3 million in stock repurchases, while operating cash flow reached a record $283.8 million; the Bachan's acquisition, financed by a $200 million term loan, contributed $15.4 million to Q4 retail sales and showed 8.7% sales growth in Circana data. Fiscal 2027 outlook anticipates sales growth in the Retail segment from the Bachan's integration and new product launches, and in the Foodservice segment from key restaurant accounts, though management warns that inflation, the Cyclospora outbreak, and consumer behavior may impact topline performance.

8. Aug 21, 2026, 7:03 AM ET·BJ·Consumer Defensive

   BJ's Wholesale Club Holdings, Inc. — Second Quarter Fiscal 2026 Earnings Summary

   BJ'S WHOLESALE CLUB HOLDINGS INC

   Net sales rose 15.9% year-over-year to $6.09 billion in Q2, while net income and diluted EPS grew 15.4% and 19.3% respectively to $173.9 million and $1.36. Full-year adjusted EPS guidance was raised to $4.60–$4.80, with comparable club sales (excluding gasoline) maintained at a 2.0%–3.0% increase; membership count reached a record 8.5 million. Capital return activity included $330.7 million in share repurchases over the first six months, leaving $422.1 million available under the existing program. The company opened three new clubs and one gas station in Q2, with fiscal 2026 capital expenditures estimated at approximately $800 million.

9. Aug 20, 2026, 4:10 PM ET·FLO·Consumer Defensive

   Flowers Foods — Second Quarter 2026 Earnings Summary

   FLOWERS FOODS INC

   Net sales decreased 4.0% year-over-year to $1.193 billion, driven by a 7.6% volume decline in Branded Retail and a 3.4% decline in Other segments, while net income fell 30.3% to $40.7 million and adjusted EBITDA dropped 19.2% to $111.3 million. The company lowered full-year 2026 guidance across all key metrics: net sales to $5.070–$5.142 billion, adjusted EBITDA to $453–$481 million, and adjusted diluted EPS to $0.75–$0.85, citing a more difficult operating environment than anticipated. Strategic initiatives include the relaunch of Nature's Own with improved positioning, organizational realignment to simplify operations, and accelerated innovation to sharpen value propositions amid macroeconomic pressures and rising labor and freight costs. Capital allocation and balance sheet activity included year-to-date capital expenditures of $44.5 million, dividends paid of $81.0 million, and a reduction in long-term debt from $1.755 billion to $1.686 billion.

10. Aug 20, 2026, 4:05 PM ET·SCNX·Consumer Defensive

    Scienture Holdings, Inc. — Q2 2026 Earnings Summary

    SCIENTURE HOLDINGS INC

    Q2 2026 revenue surged 510% sequentially to $343,639, while first-half 2026 revenue grew significantly year-over-year to $399,964; gross margins remained robust at approximately 97.7% in Q2 and 97.4% for the first half. Net loss narrowed 58% year-over-year to $2.8 million in Q2 and 36% to $6.2 million for the first half of 2026, driven by a 41% year-over-year reduction in operating expenses to $3.0 million. Management expects to accelerate top-line growth in the second half of 2026 and into 2027, with a clear path to profitability targeted for 2027. The company commercially launched REZENOPY™ nasal spray in Q2, securing formulary coverage with a large national health plan, while expanding ARBLI™ coverage to an additional 12.5 million lives. Cash and equivalents increased to $11.2 million as of June 30, 2026, up from $6.7 million at year-end 2025, though total liabilities rose to $23.6 million due to new debt and deferred tax liabilities.

11. Aug 20, 2026, 12:12 PM ET·SLSN·Consumer Defensive

    Solésence — Second Quarter 2026 Earnings Summary

    SOLESENCE INC

    Second-quarter revenue declined to $15.3 million from $20.4 million in Q2 2025, while net income reversed to a $158,000 loss compared to $3.2 million net income in the prior-year period. Gross profit fell to $4.7 million from $6.4 million, and gross margin compressed to 31% from 32%, with Adjusted EBITDA dropping to $523,000 from $3.7 million year-over-year. Liquidity and balance sheet pressures increased, with cash and cash equivalents decreasing to $1.0 million and total current liabilities rising to $26.0 million from $13.9 million in December 2025. Management is executing a "Transform and Transcend" strategy focused on operational discipline and financial structure, though the company cites risks regarding customer concentration and market acceptance. No specific forward guidance, M&A activity, or capital return programs were disclosed; the company noted a completed evaluation of historical inventory costing methodologies and filed its Form 10-Q with the SEC.

12. Aug 20, 2026, 9:06 AM ET·SBEV·Consumer Defensive

    Splash Beverage Group — Second Quarter 2026 Earnings Summary

    SPLASH BEVERAGE GROUP INC

    Loss from continuing operations for the six months ended June 30, 2026, was approximately $4 million, representing a 64% year-over-year improvement compared to $11 million in the same period of 2025, driven by significant cost-reduction initiatives and reduced corporate overhead. The company is executing a strategic pivot from alcoholic beverages to a cannabinoid-based health sciences platform, highlighted by an exclusive global license for the pharmaceutical-grade CannEpil® product and a collaboration with Lupvindol Biosciences to develop veterinary therapeutics. Corporate rebranding to Endovia Health Sciences, including a ticker symbol change, is scheduled to take effect on the NYSE American beginning August 24, 2026, as the firm shifts focus to FDA-regulated human and veterinary drug development. Management expects to maintain the 64% year-over-year loss reduction trajectory for the six-month period while prioritizing responsible capital allocation and measurable milestones, though risks regarding capital raising, regulatory approvals, and debt obligations remain.

13. Aug 20, 2026, 6:59 AM ET·WMT·Consumer Defensive

    Walmart — Q2 FY27 Earnings Summary

    WALMART INC

    Q2 revenue grew 5.9% to $187.9 billion, while operating income surged 28.8% to $9.383 billion; GAAP EPS was $0.80 and adjusted EPS was $0.81. Management raised full-year FY27 guidance for net sales growth (4.0%–5.0%), adjusted operating income (7.0%–8.5%), and adjusted EPS ($2.80–$2.87), citing strong performance in U.S. and international segments. Global eCommerce sales increased 23% and advertising revenue grew 38%, with Walmart U.S. and Sam's Club reporting significant comp sales gains driven by transactions and unit volumes. The company repurchased $5.1 billion of shares year-to-date, leaving $25.1 billion remaining on its authorization, while capital expenditures are expected to rise to 4.0% of net sales for FY27. Q3 outlook includes a 100+ basis point sales headwind due to Flipkart's Big Billion Days timing shift, though management expects to prioritize tariff refunds into price investments and customer experience in the second half of the year.

14. Aug 19, 2026, 4:31 PM ET·COTY·Consumer Defensive

    Coty Inc. — Fourth Quarter Fiscal Year 2026 Earnings Summary

    COTY INC

    Financial Results: Q4 FY26 net revenues rose 1% YoY to $1,269.2 million (LFL -1%), while full-year revenues fell 2% reported (LFL -5%) to $5,806.6 million; reported operating loss widened to $81.5 million for FY26 (vs. $241.1M income prior year), though adjusted operating income declined 27% YoY to $626.7M and adjusted net income for FY26 was $185.1M. Strategic Transactions & Capital: The company monetized its remaining Wella stake for $750M in Dec 2025 and agreed to sell the Gucci Beauty license back to Kering for $400M plus inventory proceeds in July 2026, with net debt reduced to $2,912.1M and leverage at 3.4x. FY27 Outlook: FY27 is designated a transition year with Q1 FY27 LFL revenue expected to decline low- to mid-single digits and adjusted EBITDA down low-teens YoY, though performance is projected to strengthen progressively as the strategic review concludes by end-2026. Operational Priorities: Management is executing a fixed cost reduction program and rightsizing functions to mitigate the FY28 impact of the Gucci exit, while advancing the "Coty.Curated" framework and targeting improved sell-out performance against market levels.

15. Aug 19, 2026, 4:13 PM ET·JBSS·Consumer Defensive

    John B. Sanfilippo & Son, Inc. — Fiscal 2026 Earnings Summary

    SANFILIPPO JOHN B & SON INC

    Fiscal 2026 net sales reached a record $1.18 billion (up 6.2% YoY), though Q4 gross margin declined to 15.7% from 18.1% due to elevated input and transportation costs, resulting in a 38.3% YoY drop in Q4 diluted EPS to $0.71 despite a 4.6% increase in full-year diluted EPS to $5.26. Management announced a leadership transition effective October 2026, with CEO Jeffrey T. Sanfilippo moving to Executive Chairman and his brother Jasper Sanfilippo succeeding as CEO, while expressing confidence in operational efficiency improvements for fiscal 2027. Capital returns were strengthened with a 5.6% increase in the annual dividend to $0.95 per share and a special dividend of $1.05 per share, marking the 15th consecutive year of shareholder returns. Strategic growth was driven by a 12.6% volume increase in the Contract Manufacturing channel from a new customer and 0.8% growth in Consumer Distribution, partially offset by a 5.4% decline in Commercial Ingredients and a $2.7 million charge related to a dry milk powder recall.

16. Aug 19, 2026, 8:02 AM ET·EL·Consumer Defensive

    The Estée Lauder Companies — Fiscal 2026 Earnings Summary

    ESTEE LAUDER COMPANIES INC

    Financial Performance: Full-year net sales rose 5% year-over-year to $15.049 billion, with adjusted operating income turning positive at $1.687 billion (up 47%) and adjusted diluted EPS surging 66% to $2.51; gross margin expanded 150 basis points to 75.5% driven by the Profit Recovery and Growth Plan. Guidance & Outlook: The company raised its fiscal 2027 adjusted operating margin outlook to 12.7%–13.5% (previously 12.5%–13.0%) and forecasted adjusted diluted EPS of $3.10–$3.35, while affirming organic sales growth of 3%–5% and anticipating stronger first-half growth due to new product launches. Strategic & Capital Actions: Capital expenditures decreased to $457 million with over 75% allocated to consumer-facing investments, while the company paid $508 million in dividends and $300 million in deferred consideration for the TOM FORD acquisition. Segment & Market Highlights: Skin Care and Fragrance drove growth with 4% and 10% organic sales increases respectively, while the number of billion-dollar brands reached six; the firm achieved prestige beauty value share gains across key global markets including the U.S. and Western Europe.

17. Aug 19, 2026, 7:51 AM ET·TGT·Consumer Defensive

    Target Corporation — Q2 2026 Earnings Summary

    TARGET CORP

    Second quarter net sales rose 5.3% year-over-year to $26.5 billion, with comparable sales up 3.8% driven by a 3.6% increase in traffic; GAAP and Adjusted EPS reached $4.11, a 100% increase from the prior year, including $1.65 per share in tariff refund benefits. Full-year 2026 guidance was raised to net sales growth of approximately 5% and an operating income margin rate of around 6%, with updated EPS guidance set at $9.90 to $10.90, inclusive of the $1.65 tariff refund benefit. Operating income margin expanded to 9.6% (up from 5.2% prior year), including a 3.7 percentage point benefit from tariff refunds, while gross margin excluding refunds expanded 100 basis points to 30.0%. Strategic highlights include double-digit growth in Hardlines, 8.7% digital comparable sales growth, and a store count increase to 2,019; capital expenditures rose 27% year-over-year to $1.4 billion. The company paid $518 million in dividends reflecting a 1.8% increase in the per-share rate, did not repurchase stock in the quarter, and maintains $8.3 billion of remaining capacity under its repurchase program.

18. Aug 18, 2026, 7:43 AM ET·MEDS·Consumer Defensive

    DataMeds AI — Second Quarter 2026 Earnings Summary

    DATAMEDS AI INC

    Net revenues declined 77% year-over-year to $1.779 million (down from $7.79 million in Q2 2025) despite 14% sequential growth from Q1, while net loss widened to $18.363 million from $6.672 million in the prior year period, driven by $8.88 million in debt extinguishment expenses. The company raised $6.5 million in new funding in June 2026 and restructured $14.5 million in debt, resulting in cash and cash equivalents increasing to $2.456 million, though total liabilities rose to $52.26 million and stockholders' equity deficit widened to $(19.50) million. Strategic initiatives include the planned September 2026 launch of the "Health Lives Here" consumer app with NFL Alumni Health, the H2 2026 launch of the "Forzet" medical food, and the anticipated closing of the Datavault Transaction in the second half of 2026. Corporate restructuring involved a name change to DataMeds AI, Inc. and a 1:50 reverse stock split in May 2026 to address NASDAQ delisting risks, alongside the termination of the Neuritek Therapeutics acquisition and the acquisition of controlling interest in Tollo Health.

19. Aug 17, 2026, 4:01 PM ET·MEHA·Consumer Defensive

    Functional Brands Inc. — Second Quarter 2026 Earnings Summary

    FUNCTIONAL BRANDS INC

    Revenue grew 2% year-over-year to $1.87 million for the quarter and 3% to $3.52 million for the six months, driven by direct-to-consumer and contract manufacturing channels, while gross margin expanded to 59.9% and 59.2% respectively. Operating and net losses widened significantly, with Q2 net loss reaching $2.63 million ($0.06/share) compared to $0.23 million in the prior year, primarily due to a $1.31 million increase in other expenses including non-cash derivative fair value changes and a $6.31 million non-cash loss on preferred stock issuance. The company faces substantial liquidity constraints with $352,142 in cash, a $2.90 million working capital deficit, and a $943,457 net cash usage in operating activities for the first half of the year, raising going concern doubts. Strategic setbacks include the termination of the binding letter of intent for the BullionFX blockchain asset acquisition and the delisting of common stock from Nasdaq to trade on OTC Markets under the ticker "MEHA." Management's immediate focus remains on strengthening the balance sheet, managing increased public-company operating costs, and executing on the core nutraceutical business despite the lack of assurance regarding additional financing availability.

20. Aug 17, 2026, 8:44 AM ET·AMSS·Consumer Defensive

    AMASS Brands Inc. — Second Quarter 2026 Earnings Summary

    AMASS BRANDS

    Q2 2026 net revenue rose 2% year-over-year to $5.6 million, driven by a 12% growth in Core Brands (now 67% of brand-attributed revenue) and a 132% surge in the Non-Alcoholic and Functional segment, though the company reported a net loss of $7.5 million ($0.69 per share) versus $1.3 million in the prior-year quarter. Management introduced initial guidance projecting full-year 2026 net revenues of at least $18.5 million (approx. 4% growth) and full-year 2027 revenues of at least $22.2 million (approx. 20% growth), assuming stable input costs and successful distribution expansion. Strategic portfolio transformation accelerated with Good Twin becoming the #1 organic non-alcoholic wine brand in the U.S. and Pizzolato MUSE claiming the #1 spot in organic sparkling wine, alongside the launch of AMASS Electrolyte Mixers and a planned acquisition of a majority stake in HpO Sparkling Protein Water. The company faces substantial doubt regarding its ability to continue as a going concern, citing a net loss of $7.5 million, $25.4 million in current liabilities, and a critical need to raise additional capital to avoid potential Nasdaq delisting and refinance past-due notes.

21. Aug 14, 2026, 4:15 PM ET·GNLN·Consumer Defensive

    Greenlane Holdings, Inc. — Second Quarter 2026 Earnings Summary

    GREENLANE HOLDINGS INC

    Financial Results: Q2 2026 net revenue fell 90% year-over-year to $82,000, while staking and yield revenue reached $309,000; the company reported a net loss of $(24.8) million driven by a $(19.1) million non-cash change in fair value of digital assets and $(1.8) million in impairment, compared to a $(3.2) million loss in Q2 2025. Cost Management & Liquidity: Total operating expenses decreased 37% sequentially to $3.6 million, primarily due to a 49% reduction in payroll costs, though cash and cash equivalents declined to $6.1 million from $32.5 million at year-end 2025. Strategic Positioning: The company advanced its BERA Strategy, increasing holdings to 81.3 million units and raising BERA-per-share by 37% to 117 units, while deploying $1.2 million into BERA assets and $4.1 million into stablecoin-related protocol instruments during the quarter. Listing Compliance Risk: The company faces potential delisting risks as its market value of listed securities remains below the $5.0 million Nasdaq threshold, though a stay on the SEC approval order prevents an immediate deficiency notice. Future Outlook: Management remains focused on disciplined execution of the BERA Strategy, prudent liquidity management, and is actively evaluating alternatives to meet Nasdaq listing requirements.

22. Aug 14, 2026, 7:45 AM ET·EDBL·Consumer Defensive

    Edible Garden AG — Second Quarter 2026 Earnings Summary

    EDIBLE GARDEN AG INC

    Revenue rose 12.8% year-over-year to $3.6 million for Q2 2026, with total sales growing 31.2% and net loss narrowing to $3.3 million from $4.0 million in the prior-year period. Significant balance sheet shifts occurred as cash reserves declined to $658,000 and long-term debt surged to $12.2 million from $215,000, while SG&A expenses fell 21.5% to $3.1 million. Product lines showed robust growth, with condiments surging 594.7%, cut herbs up 42%, and international vitamins rising 50%, driven by new placements with major retailers including Kroger, Target, and Safeway. Strategic focus is pivoting toward RTD clean nutrition manufacturing, evidenced by the expansion of the Prairie Hills facility to a capacity of over 100 million units annually and completed RTD prototype production. Management highlighted strengthened long-term visibility through a new multi-year private-label agreement with a major Midwest retailer and ongoing efforts to improve operating leverage via distribution center deliveries in the Metro New York market.

23. Aug 13, 2026, 4:31 PM ET·KIDZ·Consumer Defensive

    KIDZ AI Inc. — Second Quarter 2026 Earnings Summary

    KIDZ AI INC

    Service revenue declined 34% year-over-year to $0.48 million, while net loss narrowed 35% to $2.50 million; gross margin held steady at 44%. Balance sheet strengthened significantly with cash and restricted cash tripling to $8.88 million, total liabilities dropping 65.6% to $4.05 million, and the liabilities-to-equity ratio improving from 3.12x to 0.41x. Company pivoted from tutoring to AI infrastructure, formally changing its name to KIDZ AI Inc., initiating initial GPU cluster deployments, and preparing the commercial rollout of KIDZBot robotics. Management anticipates AI compute revenue will provide a scalable growth foundation as the firm transitions away from a purely tutoring-based model, though risks remain regarding GPU acquisition and execution timing.

24. Aug 13, 2026, 4:20 PM ET·KLC·Consumer Defensive

    KinderCare Learning Companies — Second Quarter 2026 Earnings Summary

    KINDERCARE LEARNING COMPANIES INC

    Reported Q2 2026 revenue of $697.5 million (down 0.4% YoY) and a net loss of $8.8 million, contrasting with Q2 2025 net income of $38.6 million; Adjusted EBITDA fell 23.6% YoY to $63.0 million. Updated full-year 2026 guidance to revenue of $2.66–$2.70 billion, Adjusted EBITDA of $200–$220 million, and diluted Adjusted Net Income per share of $0.05–$0.15. Executed center optimization by closing 49 early childhood education centers, resulting in a 4.0% enrollment decline in that segment offset by a 13.4% revenue increase in before- and after-school sites. Recognized significant impairment charges, including $22.9 million in Q2 and $273.5 million in goodwill for the first half of 2026, driven by center closures and lower operational performance. Maintained liquidity with $173.7 million in cash and $187.7 million in available borrowing capacity; noted a material weakness in internal control over financial reporting.

25. Aug 13, 2026, 4:07 PM ET·ENHA·Consumer Defensive

    Enhanced Group, Inc. — Second Quarter 2026 Earnings Summary

    ENHANCED GROUP INC

    Reported $17.7 million in Q2 2026 revenue driven by inaugural Enhanced Games sponsorship, contrasting with $0 in the prior-year period, while net loss widened to $61.9 million from $3.0 million year-over-year. Cash and cash equivalents decreased to $19.6 million as of June 30, 2026, from $25.3 million at year-end 2025, with $44.0 million used in operating activities during the first half of 2026. Secured $32 million in aggregate sponsorship value and raised $50 million in PIPE financing, with $3.3 million received and $13.3 million expected by August 14, 2026. Management expects to recognize remaining sponsorship revenue as performance obligations are satisfied and plans to expand beyond the annual Games model via the Enhanced Breakers Series. The company is evaluating strategic M&A opportunities and anticipates regulatory tailwinds in the peptide space to distinguish its medically supervised operations from the unregulated market.